- Optimal Tailored Screening Protocol after Living Donor Liver Transplantation for Hepatocellular Carcinoma
-
Park MS, Lee KW, Yi NJ, Choi YR, Kim H, Hong G, Suh KS, Kwon CH, Joh JW, Lee SK
- KMID: 2129625
- J Korean Med Sci.
- 2014 Oct;29(10):1360-1366.
- doi: 10.3346/jkms.2014.29.10.1360
The indication for hepatocellular carcinoma (HCC) is expanding in living donor liver transplantation (LDLT). Early detection and effective management of recurrence has become an important issue in LDLT for HCC.... -
- CITED
-
- Close
- SHARE
-
- Close
- Alteration of laboratory findings after radiofrequency ablation of hepatocellular carcinoma: relationship to severity of the underlying liver disease and the ablation volume
-
Shin SW, Jeong WK, Lim S, Kim Y, Kim J
- KMID: 2155293
- Clin Mol Hepatol.
- 2015 Mar;21(1):71-79.
- doi: 10.3350/cmh.2015.21.1.71
BACKGROUND/AIMS: To investigate sequential changes in laboratory markers after radiofrequency ablation (RFA) of hepatocellular carcinoma (HCC) and the relationship of these changes to the severity of the underlying liver disease. METHODS:... -
- CITED
-
- Close
- SHARE
-
- Close
- Percutaneous Radiofrequency Ablation for the Hepatocellular Carcinoma Abutting the Diaphragm: Assessment of Safety and Therapeutic Efficacy
-
Kang TW, Rhim H, Kim EY, Kim YS, Choi D, Lee WJ, Lim HK
- KMID: 1088676
- Korean J Radiol.
- 2009 Feb;10(1):34-42.
- doi: 10.3348/kjr.2009.10.1.34
OBJECTIVE: To assess the safety and therapeutic efficacy of a percutaneous radiofrequency (RF) ablation for the hepatocellular carcinoma (HCC) abutting the diaphragm. MATERIALS AND METHODS: We retrospectively assessed 80 patients... -
- CITED
-
- Close
- SHARE
-
- Close
